Description of goals of treating atrial fibrillation. Rhythm vs rate control and anticoagulation.
Просмотров: 567 Diego Belardi
In this video we try to explain two of the key issues for the management of atrial fibrillation. 1.The first issue is the issue of heart rate control versus heart rhythm control. Will your physician try to just control your heart rate or try to flip your rhythm back in to sinus rhythm from atrial fibrillation? With heart rate control our goal is to try to control the heart rate only. Thus the patient could still be in atrial fibrillation however heart rate is brought under control (60-110 bpm) with medications like beta blockers- metoprolol and calcium channel blockers like diltiazem etc. By rhythm control the physician tries to reset the heart into into sinus rhythm from atrial fibrillation. This can be done with the help of medications and is called as chemical cardioversion. Or it can be done by electrical shock also known as electrical cardioversion. Medications that can be used to keep the patient in the rhythm. These medications include, flecanide, sotalol or amiodarone etc. 2. The second key issue in the management of atrial fibrillation is prevention of stroke. Stroke is a deadly complication of atrial fibrillation. The first question that arises is what is the risk of stroke in a given patient with atrial fibrillation. A patients risk of stroke can be calculated by using an abbreviation called CHAD2VASC2 (explained in the table). Blood thinners (like Coumadin or newer agents like xeralto/apixaban/rivaroxaban) are recommended for patients with a score more than 2. For a score of zero usually no blood are recommended and for patients with the score of one either blood thinner or are aspirin as recommended. If you like this video and would like to see more of such patient educational videos go to our website www.patienteducationpro.com.
Просмотров: 1429 PatientEducationPro
"New Anticoagulants for Stroke Prevention in Atrial Fibrillation" Christian Ruff, MD Treatment Options for Atrial Fibrillation and VTE March 4th, 2013 Brigham and Women's Hospital Boston, MA
Просмотров: 10256 NAThrombosisForum
While warfarin has long been a common treatment option for patients with atrial fibrillation new medications are coming to the market which provide different benefits than the original option.
Просмотров: 2847 MD Magazine
Dr. Kneller discusses discuses treatment strategies for atrial fibrillation. Considerations include rhythm control (stopping and preventing atrial fibrillation) and rate control (slowing down the rapid heart rate caused by atrial fibrillation, without attempting to restore a normal rhythm), and whether systemic anticoagulation medication (ie, Xarelto, Eliquis, Pradaxa, or warfarin) is needed. Anti-arrhythmic medications (ie, flecainide, propafenone, sotalol, tikosyn) or catheter ablation are used to restore normal rhythm.
Просмотров: 3078 JamesKnellerMD
ford brewer md mph . PrevMedHeartRisk.com There are a lot of blood thinners in the herbal medicine list: garlic, nattokinase, ginger, cinnamon, cassia, vitamin e, ginkgobiloba, grape seed extract, cayenne, aspirin, apple cider vinegar, cod liver oil, etc. Most of these are antiplatelets, not anticoagulants. Anticoagulants have been shown to be more effective in terms of prevention of strokes. Safety is also an issue. The strokes we're preventing are infarction, embolic, or ischemic strokes. So, we decrease the formation of blood clots. Unfortunately, that also increases the risk for serious bleeding or hemorrhage, such as hemorrhagic strokes. The research has been clear for over 20 years that anticoagulants seem better than antiplatelets for stroke prevention. And most docs will go with the researched recommendations. These days the researched recommendations are leaning more and more toward the NOACs, the New Oral Anti Coagulants. I have other videos in a series on stroke prevention and atrial fib. About Dr. Brewer - Ford Brewer is a physician that started as an Emergency Doctor. After seeing too many patients coming in dead from early heart attacks, he went to Johns Hopkins to learn Preventive Medicine. He went on the run the post-graduate training program (residency) in Preventive Medicine at Hopkins. From there, he made a career of practicing and managing preventive medicine and primary care clinics. His later role in this area was Chief Medical Officer for Premise, which has over 500 primary care/ prevention clinics. He was also the Chief Medical Officer for MDLIVE, the second largest telemedicine company. More recently, he founded PrevMed, a heart attack, stroke, and diabetes prevention clinic. At PrevMed, we focus on heart attack and stroke and Type 2 diabetes prevention by reducing or eliminating risk through attentive care and state-of-the-art genetic testing, imaging, labs and telemedicine options. We serve patients who have already experienced an event as well as those have not developed a diagnosis or event. Our team of senior clinicians includes internationally recognized leaders in the research and treatment of cardiovascular disease, preventive medicine and wellness. We also provide preventive medicine by telemedicine technology to over 30 states. Contact Dr. Brewer at email@example.com or visit http://prevmedheartrisk.com.
Просмотров: 3856 Ford Brewer
http://www.stopafib.org StopAfib.org interviews Dr. Eric Prystowsky of St. Vincent's Hospital in Indianapolis, Indiana Find more on Dr. Prystowsky: http://www.stopafib.org/newsitem.cfm/NEWSID/417 Find more on rate control for the treatment of afib at: http://www.stopafib.org/rate-control.cfm In this video, Dr. Prystowsky discussed the proper application of rate control as a method of controlling atrial fibrillation, as well as which patients may be most appropriately treated with rate control. Dr. Prystowsky currently serves as the Director of the Clinical Electrophysiology Laboratory at St. Vincent's Hospital, and as a Consulting Professor of Medicine at Duke University. He is a former President of the Heart Rhythm Society, and is one of the leading clinical cardiac electrophysiologists in the world.
Просмотров: 3408 StopAfib
If you've looked at the research regarding cardiac arrhythmias then you might have noticed that all the doctors and researchers are focused on the heart and the nodes that control heart function, however, Dr. Bergman explains the one thing everyone is missing... The Autonomic Nervous System. Dr. Bergman's Website https://drjohnbergman.com/ Dr. Bergman's Facebook page: https://www.facebook.com/drjohnbergman/ Dr. Bergman's Clinic: http://bergmanchiropractic.com 714-962-5891 Office Hours: Monday 5:15am 6:00pm Tuesday 6:30am 6:00pm Wednesday 5:15am 6:00pm Thursday 5:15am 6:00pm Friday 6:30am 6:00pm Saturday Closed Closed Sunday Closed Closed Dr. Bergman is available for Skype and Phone consultations which you can schedule by using the link below: https://drjohnbergman.com/online-consultations/booking-consultations/ For Media and Business Inquires contact: firstname.lastname@example.org
Просмотров: 131101 Dr. John Bergman
Join our channel by subscribing here. If you have enjoyed our video, please like it and leave a comment about what other videos you may be interested in. Your help in creating great, relevant content is greatly appreciated. Although it was thought for many years that aspirin was sufficient to 'thin' your blood to prevent blood clots inside the heart from forming, the latest evidence is that aspirin is just not effective enough in people who have atrial fibrillation associated with other risk factors, including being elderly! This video describes the role of aspirin in managing patients with atrial fibrillation. Transcript: Thank you for visiting Doctor AFib, I'm Dr. Morales. In today's video segment we're going to be talking about the role of aspirin when it comes to managing atrial fibrillation. In a previous video segment, I discussed your risk of stroke with atrial fibrillation as defined by the CHADSVASc risk score. Most people who have atrial fibrillation are going to have a CHADSVASc score of two or greater and it's going to be recommended to take stronger blood thinners, something called anticoagulation. However, when I explain it to the patients, probably the next question is: what about an aspirin? Can I take an aspirin for atrial fibrillation? So, let's look at the data regarding aspirin for atrial fibrillation. Aspirin has been studied for atrial fibrillation since the late 80s and early 90s and in multiple clinical trials. Back in 2007, there was a meta-analysis which combined the results of several studies and showed that aspirin provides a reduction in the rate of stroke by about 22%. Most studies in the 80s and 90s used aspirin 325 milligrams daily. A later study called the Active W trial looked at the combination of aspirin together with Plavix and that reduced your risk of stroke by about 44%. However, in that same meta-analysis in 2007, it showed that Warfarin, also called Coumadin, reduced risk of stroke in atrial fibrillation by about 66%. Several studies were done back in the late 80s or 90s early 2000s looking at comparing aspirin with Warfarin and every time Warfarin was found to be superior to aspirin for reducing your risk of stroke. As a result, for many years Warfarin became the standard of care for reducing the risk of stroke because it was far better in terms of the reduction amount for reducing the risk of stroke. Fortunately, these days there are other options, where newer blood thinners have come out as an alternative to Warfarin. Listen to the video for more Read my blog posts at http://www.DrAFib.com
Просмотров: 288 Dr. AFib
Join our channel by subscribing here. If you have enjoyed our video, please like it and leave a comment about what other videos you may be interested in. Your help in creating great, relevant content is greatly appreciated. Discover everything patients should know about the blood thinner Coumadin (Warfarin). I cover the mechanism of action against vitamin K, the conditions it treats (including atrial fibrillation and deep vein thrombosis a.k.a DVT), the INR and how it should be monitored. This video describes the role of Warfarin in managing atrial fibrillation. Also included are modern day pros and cons of still using this medication that has been available for well over 50 years. Transcript: Thank you for visiting doctor AFib, I'm Dr. Morales. In today's video segment we're going to be talking about a blood thinner that has been on the market for well over 50 years, known as Warfarin or also goes by the brand name of Coumadin.Yes, it was first advertised and marketed as a rat poison way back in the 1940s. But starting in the 1950s it began to be approved for human use as a blood thinner.Nowadays it's actually used for several purposes, including for reducing the risk of stroke for atrial fibrillation, but also for treating deep venous thrombosis, pulmonary embolism as well as an anticoagulant for mechanical heart valves. Starting in the late 1980s and into the 1990s there were several clinical trials comparing Warfarin with aspirin for reducing the risk of stroke for atrial fibrillation.Several times Warfarin was shown to be superior for reducing the risk of stroke.In meta-analysis where they combined data from several clinical trials, it showed that Warfarin reduces the risk of stroke by about 66 percent. However, there are a lot of nuances when it comes to managing somebody who has taken Warfarin. First of all, not everybody's dose is the same based on how individuals metabolize the medication. There's a blood test called an INR, which helps your doctor monitor your Warfarin level to find the right dosage for you.At the beginning, very frequently people will have the blood tested every week until you find the correct dosage for you.After that stage, it may be only checked about once a month The target level on the blood test for most people is between a level between two to three in that INR blood test. However, there's been several studies that have shown that the amount of time people are actually within that recommended range can range anywhere from 50 to 70 percent of the time which shows that at least 30% of the time or even more patients are not within the recommended range of that INR level. Listen to the video for more Read my blog posts at http://www.DrAFib.com
Просмотров: 263 Dr. AFib
http://www.stopafib.org StopAfib.org interviews Dr. Daniel Singer of Harvard Medical School. Find more information on this topic, and Dr. Singer, at: http://www.stopafib.org/newsitem.cfm/NEWSID/397 Dr. Singer led a symposium on atrial fibrillation stroke prevention at Boston Atrial Fibrillation Symposium 2012. In this video interview, Dr. Singer shared with StopAfib.org information from that symposium. He provided an update on rivaroxaban (Xarelto), which was recently approved by the FDA, and talked about the results of the two trials of apixaban (Eliquis), AVERROES and ARISTOTLE, against aspirin and warfarin, respectively. He also mentioned edoxaban, which should finish trials in 2012, and that we now have a year of results in clinical practice with dabigatran (Pradaxa). He also mentioned that the new drugs have all shown better results than warfarin (Coumadin) in preventing intracranial bleeding (bleeding in the brain). He confirmed that patients will have a lot of new choices soon, but that cost will continue to be an issue. Dr. Singer is a Professor of Medicine at Harvard Medical School, Professor of Epidemiology at the Harvard School of Public Health, and Chief of the Clinical Epidemiology Unit at Massachusetts General Hospital.
Просмотров: 3030 StopAfib
Anne O'Connor, MD and Jennifer Wright, MD co-present a lecture about clinical management of atrial fibrillation. Dr. O'Connor is an Associate Professor (CHS) whose clinical interests include critical cardiology, reducing readmissions for heart failure and acute myocardial infarct patients, and cardiovascular imaging. Dr. Wright is a Clinical Assistant Professor who specializes in cardiology and electrophysiology. Both are members of the Division of Cardiovascular Medicine in the Department of Medicine at UW-Madison. The title of their June 16, 2017 Grand Rounds talk is "Atrial Fibrillation: Can We Organize the Chaos?" University of Wisconsin Department of Medicine Grand Rounds are presented throughout the academic year and are intended for health care professionals and medical researchers. Unless otherwise indicated, Grand Rounds occurs in the William S. Middleton Memorial Veterans Hospital auditorium, Room A1028, Madison, Wisconsin. All faculty and staff are invited and encouraged to attend. For more information on the Grand Rounds lecture series, visit http://www.medicine.wisc.edu/dom/medicine-grand-rounds
Просмотров: 1850 UW Department of Medicine
Sunil Rao John Alexander
Просмотров: 137 Duke Clinical Research Institute
Teresa Tsang, MD, FRCPC, FACC, FASE, Vancouver, BC; John Cairns, MD, FRCPC, FRCP (Lond), FCAHS, FACC;Jason Andrade, MD, FRCPC Atrial fibrillation (AF) is the most common arrhythmia managed by physicians. Most patients with AF or atrial flutter (AFL) have poor quality of life due to the symptomatology of the disease, making the management strategy a key component of symptoms improvement, reduction of hospitalizations, and prevention of further complications, such as stroke. The Canadian Cardiovascular Society (CCS) Atrial Fibrillation Guidelines Program has generated a comprehensive series of documents regarding the management of AF between 2010 and 2016.
Просмотров: 9174 CFPCMedia
An in-depth conversation between Pentucket Medical cardiologists Seth Bilazarian and Sunny Srivastava, focusing on a newly released medicine to reduce the risks of atrial fibrillation. The latest among recently approved blood thinners, Eliquis joins Pradaxa and Xarelto as an alternative to Coumadin, a drug that has been in use since the 1950s. Like Pradaxa and Xarelto, Eliquis has been shown to reduce risk of stroke and bleeding, as well as mortality. All the new drugs eliminate the need for regular blood testing that Coumadin necessitates.
Просмотров: 25433 PentucketMedical
Houston Methodist DeBakey Heart & Vascular Center Grand Rounds “Rate Control versus Rhythm Control for Atrial Fibrillation” Fred Morady, MD October 6, 2016
Просмотров: 1440 DeBakey Institute For Cardiovascular Education & Training
Sarah Spinler, PharmD, professor of clinical pharmacy at the Philadelphia College of Pharmacy, explains why some patients with atrial fibrillation should be prescribed a new oral anticoagulant (NOAC) instead of warfarin.
Просмотров: 340 Pharmacy Times TV
Learn fast with Dr. Aman Arora's short snaps! www.aroraMedicalEducation.co.uk 👉 Flagship Facebook Medical Education group: https://m.facebook.com/groups/1571643289740957 👉 Instagram: @arorameded (https://www.instagram.com/arorameded/) 👉 Twitter: @arorameded (https://mobile.twitter.com/arorameded?lang=en) 👌 This video: 💥💥💥 60 seconds on when you may consider rhythm-control for AF instead of rate-control Source/details: https://cks.nice.org.uk/atrial-fibrillation#!scenarioclarification *not for medical advice* www.aroraMedicalEducation.co.uk 💥 Immersion Courses 💥 Mock Exams 💥 Live Webinars 💥 Online Training 💥 One-to-one Sessions 💥 Revision Posters *All videos are for educational purposes only and are not to be used for medical advice. Guidance is aimed to be relevant and up-to-date at time of release*
Просмотров: 670 Aman Arora
Rajat Deo, MD, remarks on the advantages and disadvantages of warfarin use in preventing stroke in patients with nonvalvular atrial fibrillation.
Просмотров: 94 AJMCtv
Dr. Alo discusses atrial fibrillation treatment algorithms including many of the newer rate and rhythm control drugs. Also discusses the novel anticoagulation options. Target audience is informed patients and medical professionals. hhtp://MohammedAlo.com
Просмотров: 10157 Mohammed Alo
Rich Gordon and Dan McCollum discuss differences between treating Atrial Fibrillation with rapid ventricular response with rate control versus cardioversion. Rich favors rhythm control a bit more than Dan who slightly prefers rate control. Rich makes some excellent points about the need to resuscitate to maintain correct rhythm and to remember the use of heparin if you plan to cardiovert.
Просмотров: 1514 Daniel McCollum
http://www.stopafib.org Mellanie True Hills talks about the physical, emotional, and financial impact of atrial fibrillation on patients and their families through sharing her story. Share this with family and friends, and learn more at http://www.StopAfib.org, the atrial fibrillation patient resource
Просмотров: 3768 StopAfib
Mintu Turakhia, MD, MAS, discusses the use of Aspirin and why it may or may not be effective treatment for Atrial Fibrillation. Connect with other patients and learn how they manage AFib at: http://spr.ly/60578YV0J
Просмотров: 133 American Heart Association
Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions. Researcher and electrophysiologist Jared Bunch, MD, with the Intermountain Medical Center Heart Institute, explains the study, which was presented at the American Heart Association Scientific Sessions in New Orleans.
Просмотров: 68 Healthy Dialogues
Researchers have linked a widely used heart drug to increased risk of dementia. Warfarin is a blood thinner used in the treatment of atrial fibrillation, an abnormal heart rhythm that affects millions of people in the U.S. Researchers at the Intermountain Medical Center Heart Institute tracked more than 10,000 patients who took warfarin long-term, both for atrial fibrillation and for other conditions. The researchers found that patients with atrial fibrillation experienced higher rates of dementia and Alzheimer's. Within eight years, close to 6 percent of patients taking warfarin for atrial fibrillation developed dementia, compared to less than 2 percent of those taking warfarin for other reasons. This is the first study to detail the dementia risks of warfarin. Doctors warn the connections between blood thinners, atrial fibrillation and dementia are still not clearly understood. The study's lead author says because doctors are only now learning about the risks, "only those that absolutely need blood thinners should be placed on them long-term." This video includes clips from the National Institutes of Health and Intermountain Medical Center Heart Institute and images from Gonegonegone / CC BY SA 3.0. Newsy is your source for concise, unbiased video news and analysis covering the top stories from around the world. With persistent curiosity and no agenda, we strive to fuel meaningful conversations by highlighting multiple sides of every story. Newsy delivers the news and perspective you need without the hype and bias common to many news sources. See more at http://www.newsy.com/ Like Newsy on Facebook: http://www.facebook.com/newsyvideos/
Просмотров: 785 Newsy
Heart rate vs. rhythm control vs. rhythm restoration was the focus of Dr. Paul Wang’s talk at Piedmont Heart’s Napa Valley Cardiology Conference. Dr. Wang, director of Stanford’s Cardiac Arrhythmia Service, discusses the overall treatment guidelines for the management of patients with atrial fibrillation (AF) and reviews the recent 2017 AF ablation guidelines with “an important new emphasis on surgical ablation for our field.”
Просмотров: 28 Piedmont Heart Institute
http://www.stopafib.org StopAfib interviews Dr. James Reiffel Find a transcript and more on Dr. Reiffel at: http://www.stopafib.org/newsitem.cfm/NEWSID/420/ In this video interview at Heart Rhythm 2012, Dr. James Reiffel updates us on new directions in drug treatments for atrial fibrillation. He talks about the combination of ranolazine (Ranexa) and dronedarone (Multaq), both used in lower doses, and about other coming atrial-selective drugs. He also discusses the rate control vs. rhythm control decision, which varies by age and level of symptoms. Dr. Reiffel is an attending physician at New York Presbyterian Hospital, and a Professor of Clinical Medicine at the Columbia University College of Physicians & Surgeons.
Просмотров: 9176 StopAfib
Hey, this is Dr. Jack Wolfson, The Paleo Cardiologist of The Drs. Wolfson and obviously I am a board certified cardiologist and I have a lot of people from all over the world that come to see me for atrial fibrillation. And... very often when it comes to blood thinners and atrial fibrillation and stroke and atrial fibrillation, patients are very confused. I wanna set the record straight for them and really help them make an educated decision as far as what is right for them. One of the first things I do with my patients when they have atrial fibrillation and they are concerned about stroke risks or they've been prescribed pharmaceutical blood thinners such as Warfarin, otherwise known as COUMADIN, or one of the newer drugs like PRADAXA or XARELTO, I show them this website, and it's called chadsvasc.org and you can see it up here on my screen on the top left. On Chadsvasc you can go there and you can actually get lots of different information and you can figure out what your stroke risk is, and then you and your doctor can decide what's right for you. Let's take a look over here where you plug in your risk factors. So you go through this check list. Congestive heart failure, if you do have congestive heart failure as identified by this criteria, then you would give yourself a point... and so on and so forth. If you've got hypertension, or if you are on pharmaceuticals for hypertension/high blood pressure, you get a point. Age greater than 75 gets ya two points. 65 to 74 gets ya one point. Diabetes gets ya one. Stroke or TIA, by history, gets ya two points. History of vascular disease, like if you've had angioplasty, a stint, or previous bypass surgery, that gets you a point and if you are female, you get a point. So, say for example, let's take Jack Wolfson. I am 46 years old. I have never had a history of congestive heart failure. Never had hypertension. My age, I'm 46. No diabetes. No history of stroke. No history of vascular disease and I am a male. So, my score is a zero. So we go over to into this side and we see Chadsvasc score of zero. My chances of having a stroke are zero percent, If I was in full-time atrial fibrillation. We are not going to make it much lower than zero percent with any form of pharmaceuticals. Well now, let's just take the 67 year old female patient with hypertension. So that person would get a point for hypertension, they'd get a point for age, and they would get a point for being a female, that's a score of three. Now, you go over here to the Chadsvasc score of three and you can see they are a 3.2 percent stroke risk on a yearly basis. Now that's not zero, it's still one out of thirty three people in that category are having a stroke on an annual basis. But what I try and do is, I try and tell people that I don't want your risk of having a stroke to be three percent, and with a blood thinner, the pharmaceuticals, you can lower that risk down to about one to two percent. Which is still some improvement, but it's not actually getting rid of all risk. And, of course, there is the risk of bleeding on those heavy duty blood thinners. So what do we do? We talk about ways to, number one, eat the right foods, which the people in these studies are not doing. To live the right lifestyle, such as getting sunshine and sleep. And also getting chiropractor care. We talk about staying away from environmental toxins. We talk about getting grounded. We talk about all the things that I talk about in my book, The Pale Cardiologist: The Natural Way to Heart Health. But once again it's about giving people the information. Now you may think, “Hey, the Chdsvasc score of three, three percent, I'm not over concerned with that”. Maybe there are some natural blood thinners that you would be interested in. I use a lot of Nattokinase in my office and vitamin C, and Vitamin E and Garlic. There's a lot of things that, if you help keep the body working appropriately... Even Omega Threes have benefit in this category. If you keep the body working appropriately, your stroke risk is undoubtedly going to be lower. These are just some options for you. This is a fantastic website. This is not a natural website. This is not a holistic website. This is a website created by mainstream cardiologists to get this information out there to the public. Until next time... Contact us : For business inquiries: email@example.com https://www.thedrswolfson.com/ https://www.wolfsonintegrativecardiology.com/ https://www.facebook.com/TheDrsWolfson https://plus.google.com/u/0/+TheDrsWolfson https://twitter.com/thedrswolfson #Healthandwellness #naturalheart #healthcardiology #cardiologistholistic #Hearthealthytips #TheNaturalCardiologist best in Paleo Nutrition and Paleo Lifestyle, Drs. Wolfson,
Просмотров: 3240 The Drs. Wolfson
http://www.stopafib.org Get in Rhythm. Stay in Rhythm.™ Atrial Fibrillation Patient Conference See all conference videos, and download the slides, at: http://www.stopafib.org/newsitem.cfm/NEWSID/482 Here, Dr. Eric Prystowsky discusses treatments for atrial fibrillation, including rate control and rhythm control, as well as use of anticoagulants to prevent afib-related strokes. At the conclusion of his presentation, StopAfib.org founder Mellanie True Hills bestowed upon Dr. Prystowsky the first ever "Advocate for Patients" Award for his work in bringing afib patients to the table where decisions are made about our care and his ongoing quest to "Preserve the Brain" through educating doctors and patients. Learn how to get in rhythm and stay in rhythm by watching videos of the Atrial Fibrillation Patient Conference that was held in Dallas on November 2, 2013. At the conference, presentations by leading afib experts provided atrial fibrillation patients, families, and caregivers with the information to manage afib and get appropriate care. More conference videos are at: http://www.stopafib.org/newsitem.cfm/NEWSID/482/
Просмотров: 3917 StopAfib
Former Emmaus teacher Buzz Hill developed atrial fibrillation (AFib) in his late seventies. He experienced a stroke and later, also suffered a brain bleed as a result of taking the blood thinner Warfarin (Coumadin.) Many patients with AFib are at an increased risk of stroke due to blood clots which form in a pocket of the heart called the left atrial appendage (LAA). In this video, Buzz and his wife Carolyn share how they made the decision to have a device called Watchman implanted in a catheter-based procedure at Lehigh Valley Health Network. He returned home the day after the procedure, and felt well enough to return to the outdoors and enjoy one of his favorite past times, hunting.
Просмотров: 552 Lehigh Valley Health Network
Mayo Clinic cardiologist Fred Kusumoto, M.D., discusses atrial fibrillation, its signs and symptoms, and treatment options. Visit http://www.mayoclinic.org/diseases-conditions/atrial-fibrillation/home/ovc-20164923?mc_id=global&utm_source=youtube&utm_medium=sm&utm_content=dysrhythmiaheart&utm_campaign=mayoclinic&geo=global&placementsite=enterprise&cauid=103944 for more information on atrial fibrillation or to request an appointment. In atrial fibrillation, the heart beats irregularly and chaotically. Atrial fibrillation can cause a wide array of symptoms. Atrial fibrillation can be treated with medications or a procedure called catheter cardiac ablation.
Просмотров: 13303 Mayo Clinic
Many Americans take blood thinners to help manage atrial fibrillation. AFib, the most common sustained heart arrhythmia, affecting nearly three million people in the United States, can lead to severe complications like strokes if untreated. Ed Cleary came to Massachusetts General Hospital in June 2012 to get his AFib treated. He had tried taking a blood thinner to help manage his AFib, but bled too much. Fortunately, he qualified for a new procedure now being used for the first time in New England by Mass General Hospital. The Lariat® procedure is for patients who cannot be on blood thinners. The procedure, which is minimally-invasive and uses catheters, ties off the left atrial appendage by use of sutures (blood clots often appear in the LAA and can cause strokes). In this video, Moussa Mansour, MD, director of the Mass General Atrial Fibrillation Program in the Institute for Heart, Vascular and Stroke Care, talks about what the procedure does, gives a general overview of the problem for some patients with the left atrial appendage and shares Mr. Cleary's prognosis. For more information about AFib and diseases and conditions treated in the Atrial Fibrillation Program, visit: http://www.massgeneral.org/heartcenter/services/treatmentprograms.aspx?id=1565.
Просмотров: 11382 MassGeneralHospital
In a video originally posted on TheHeart.org, Win-Kuang Shen, MD, sits down with Samuel J Asirvatham, MD, and Douglas Packer, MD, for an in-depth discussion of the major issues involved in managing atrial fibrillation, from increasing patient awareness to stroke prevention and when and how to use ablation.
Просмотров: 738 Mayo Clinic
Dr David Whalley, Cardiologist at Royal North Shore Hospital, talks about the medical management of atrial fibrillation. Presentation delivered at the Structural Heart Disease Australia Left Atrium Symposium 23 July 2016.
Просмотров: 558 Structural Heart Disease Australia
Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Some people refer to AF as a quivering heart. An estimated 2.7 million Americans are living with AF.
Просмотров: 22020 American Heart Association
Rate and Rhythm Control for Atrial Fibrillation Gregory Piazza, MD North American Thrombosis Forum (NATF) Thrombosis Prevention Forum 2011 April 28, 2011 Boston, MA
Просмотров: 1394 NAThrombosisForum
Dr. S Arthnari performs on The main cause of strokes in the elderly is acquired Aortic Stenosis
Просмотров: 20 Revolution Talk
Atrial fibrillation including management
Просмотров: 17 Azib Zahid
T271 Canadian Cardiovascular Society Atrial Fibrillation Guidelines Management of AF for the family physician Dr Alan Bell (1)
Просмотров: 233 CFPCMedia
Atrial fibrillation (AF) increases stroke risk five-fold. This video explains how this risk could be reduced through appropriate anticoagulation. It features Arrhythmia Alliance and AF Association CEO, Trudie Lobban MBE, AF Association Deputy CEO, Jo Jerrome, leading heart rhythm specialist, Professor John Camm and CEO of Anticoagulation Europe, Eve Knight. Developed in association with Boehringer Ingelheim.
Просмотров: 2272 ArrhythmiaAlliance
Dr. Barry Sears Dr. Sears explains how Omega RX fish oil can improve Atrial Fibrillation. Dr. Barry Sears is a leading authority on the impact of the diet on hormonal response, genetic expression, and inflammation. A former research scientist at the Boston University School of Medicine and the Massachusetts Institute of Technology, Dr. Sears has dedicated his research efforts over the past 30 years to the study of lipids. He has published more than 30 scientific articles and holds 13 U.S. patents in the areas of intravenous drug delivery systems and hormonal regulation for the treatment of cardiovascular disease. He has also written 13 books, including the New York Times #1 best-seller "The Zone". These books have sold more than 5 million copies in the U.S. and have been translated into 22 different languages. For more, go to zonediet.com
Просмотров: 29581 Dr. Barry Sears
Dr. Subir Bhatia, an Internal Medicine physician from Mayo Clinic in Rochester, MN, discusses his article featured in the March 2018 issue of Mayo Clinic Proceedings, where he provides a comprehensive review of the rhythm control approach to atrial fibrillation and offers current medical and surgical treatment options. Available at: https://tinyurl.com/y89gyvsq
Просмотров: 32 Mayo Proceedings